Nanospectra Biosciences has filed a notice of an exempt offering of securities to raise $10,066,119.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Nanospectra Biosciences is raising $10,066,119.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Jorden played a key role…
